A national audit of pancreatic enzyme prescribing in pancreatic cancer from 2015 to 2023 in England using OpenSAFELY-TPP. (2023)
Attributed to:
Phase 1 COVID-19 Longitudinal Health and Wellbeing - National Core Study
funded by
COVID
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1101/2022.07.08.22277317
PubMed Identifier: 36093352
Publication URI: http://europepmc.org/abstract/MED/36093352
Type: Journal Article/Review
Parent Publication: medRxiv : the preprint server for health sciences